Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: sjemmeri who wrote (4519)	12/2/2005 2:22:22 PM
From: sjemmeri	Read Replies (2) of 4974

12/2/2005 NCST Medical product maker NUCRYST Pharmaceuticals files for IPO and sets terms NUCRYST Pharmaceuticals, a developer and manufacturer of innovative medical products that fight infection and inflammation, registered for an IPO Friday morning and plans to offer 5.8 million shares at a range of $12-$14. Assuming the stock prices at the midpoint, the company will have an initial market capitalization of $221 million. Jefferies heads the list of underwriters on the deal. Timing has yet to be determined.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next